Patent · US Active

Pseudoglycolipid and use thereof

US8299223B2 · kind B2 · utility

4Cited by
0References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 22, 2008
Grant dateOct 30, 2012
Priority date
Expiry dateSep 29, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C2601/14
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The invention provides a pseudoglycolipid effective for cancer treatment and the like and a novel synthesis intermediate therefor, as well as a medicament containing the pseudoglycolipid and the like. The inventive compound is represented by the formula (1), or a salt thereof,wherein each symbol is as defined in the specification.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.